Stock Picks
Find By Stock Symbol:
Stock picks every day. Check StockReads
daily for your penny stock picks. Stocks to Watch for Friday, April 20th

4/19/2012 8:16 PM
Penny Stocks by: OTC Picks

More OTC Picks

Recent Newsletters Stocks to Watch for Friday, April 20th FUEL, ROSG, AXIO, ONTC, EVCA, AMNP Our Stocks to Watch today include SMF Energy Corp. (NASDAQ: FUEL), Rosetta Genomics Ltd. (NASDAQ: ROSG), Axiom Gold & Silver Corp. (OTCBB: AXIO), Onteco Corp. (OTC: ONTC), EVCARCO Inc. (OTCBB: EVCA) and American Sierra Gold Corp. (OTCBB: AMNP).

Visit to register for our Stocks to Watch Newsletter and Email Stock Watch Alerts.

SMF ENERGY CORPORATION (NASDAQ: FUEL) "Up 62.50% on Thursday" Detailed Quote: The Company is a leading provider of petroleum product distribution services, transportation logistics and emergency response services to the trucking, manufacturing, construction, shipping, utility, energy, chemical, telecommunications and government services industries. The Company provides its services and products through 34 locations in the eleven states of Alabama, California, Florida, Georgia, Louisiana, Nevada, Mississippi, North Carolina, South Carolina, Tennessee and Texas. The broad range of services the Company offers its customers includes commercial mobile and bulk fueling; the packaging, distribution and sale of lubricants and chemicals; integrated out-sourced fuel management; transportation logistics and emergency response services. The Company`s fleet of custom specialized tank wagons, tractor-trailer transports, box trucks and customized flatbed vehicles delivers diesel fuel and gasoline to customers` locations on a regularly scheduled or as needed basis, refueling vehicles and equipment, re-supplying fixed-site and temporary bulk storage tanks, and emergency power generation systems; and distributes a wide variety of specialized petroleum products, lubricants and chemicals to our customers.

FUEL News:

April 16 - SMF Energy Corporation Files for Chapter 11 Reorganization SMF Energy Corporation (NASDAQ: FUEL), a leading energy logistics company (the "Company"), announced that the Company and its subsidiaries, H & W Petroleum Company, Inc., SMF Services, Inc., and Streicher Realty, Inc.

(collectively, the "Companies"), have filed voluntary petitions for reorganization (the "Voluntary Petitions") under Chapter 11 of the United States Bankruptcy Code (the "Bankruptcy Code"), in the United States Bankruptcy Court for the Southern District of Florida (the "Court"). The Companies will operate as "debtors in possession" under the jurisdiction of the Court, and in accordance with the applicable provisions of the Bankruptcy Code and orders of the Court.

On April 13, 2012, the Company received a declaration from Wells Fargo Bank, N.A. (the "Lender"), the Companies` principal lender, of various Events of Default, as defined in the Loan and Security Agreement dated September 26, 2002, as amended, among the Companies and the Lender (the "Loan Agreement"). The Lender also purported to revoke the authority of the Company to access its own collections of accounts receivable and declared the Lender`s intention not to make any further revolving Loans to the Company under the Loan Agreement. Without considering any penalties or additional charges resulting from the Lender`s declaration of the Events of Default, the current balance owed to the Lender under the Loan Agreement is approximately $11.2 million, consisting of around $8 million in revolving loans, a $2.2 million unpaid balance of a Term Loan, and a $1.0 million mortgage loan.

The extent of the Companies` ability to continue operating their businesses in the Chapter 11 cases is dependent on the willingness of the Lender, which asserts a security interest in substantially all of the Companies` assets, to consent to or support the Companies` use of the Lender`s cash collateral during the bankruptcy cases. It is the Company`s current expectation that the Lender will consent to or support the Companies` use of the Lender`s cash collateral to continue to operate only those portions of the Companies` business that have a discernible value as an ongoing enterprise. As a result, the Company expects that it will be required to promptly commence the liquidation of the assets of those portions of the Companies` business that are not believed to have a going concern value.

The Company previously announced, on March 16, 2012, that it expected a substantial reduction in sales revenue and earnings for the quarter ended March 31, 2012, and future periods, and that it expected to report a loss for the quarters ending March 31, 2012, and June 30, 2012, on account of necessary changes that had been made to its pricing structure. The Company also announced on March 16th that it was seeking to mitigate the adverse impact on revenue and earnings by instituting significant expense reductions and revenue enhancement measures but stated that it did not believe that those measures would be sufficient to offset the revenue and earnings downturn in the foreseeable future. The Company further stated on March 16 that it was considering an overhaul of its business model to permit it to drastically reduce its back office and interest expense in order to better match the Company`s total expenses with its revenues.

On March 22, 2012, the Company announced that it had appointed Soneet Kapila of Kapila & Company, Ft. Lauderdale, Florida, as its Chief Restructuring Officer ("CRO") to direct the Company`s efforts to increase revenues and reduce expenses required by the decision to change the Company`s pricing structure. The Company also indicated on March 22nd that it was actively pursuing strategic alternatives, including potential business combinations and the development of new business partnerships.

To date, the Company`s vigorous efforts to reduce operating losses by increasing revenue and decreasing expenses have been unsuccessful.

Competitive pressures have prevented the Company from increasing prices and, despite layoffs and other cost cutting measures, expenses have not been reduced in an amount sufficient to offset the decreased revenue since the change in pricing structure. The Company does, however, intend to continue to pursue strategic alternatives after the Voluntary Petitions for those portions of the Companies` business that have a discernible value as an ongoing enterprise.

The Company has filed a Current Report on Form 8-K with the Securities and Exchange Commission that provides additional details concerning the foregoing disclosures, including but not limited to the Lender`s April 13, 2012, letter declaring a default under the Loan Agreement.

ROSETTA GENOMICS LIMITED (NASDAQ: ROSG) "Up 18.75% on Thursday" Detailed Quote: Rosetta Genomics develops and commercializes a full range of microRNA-based molecular diagnostics. Founded in 2000, the company`s integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Building on its strong patent position and proprietary platform technologies, Rosetta Genomics is working on the application of these technologies in the development and commercialization of a full range of microRNA-based diagnostic tools. The Company`s miRview product line is commercially available through its Philadelphia-based CAP-accredited, CLIA-certified lab.

ROSG News:

April 19 - Rosetta Genomics Receives Key European Patent in Oncology Patent Awarded for the Use of miR-34a for the Preparation of Pharmaceuticals for Treating p53-Negative Cancers Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced that the Company received a grant from the European Patent Office for a patent claiming the use of miR-34a for the preparation of pharmaceuticals for treating p53-negative cancers. The issued claims cover a core element of Rosetta Genomics` microRNA technology in the development of cancer therapeutics associated with p53-negative cancers. The patent is jointly owned with Yeda, the technology transfer company of the Weizmann Institute of Science in Rehovot, Israel.

The p53 protein is a sequence-specific transcription factor that functions as a major tumor suppressor in mammals. Inactivation of the tumor-suppressor function of p53 is one of the most frequent genetic alterations in human cancer, and close to half of all human tumors carry p53 gene mutations within their cells. The invention covered by this new patent discloses the finding that miR-34a, which is a direct transcriptional target of p53, possesses anti-proliferative and pro-apoptotic activities, thereby contributing to the tumor suppressor effects of activated p53.

Overexpression of miR-34a exerts anti-proliferative effects and promotes cell death, whereas inactivation of miR-34a attenuates p53-mediated cell death. Thus, miR-34a is a direct transcriptional target of p53, which may mediate some of the biological effects of this tumor suppressor.

Perturbation of miR-34a expression may thus contribute to tumorigenesis.

Commenting on the clinical utility for such a potential microRNA-based therapeutic, Moshe Oren, Department of Molecular Cell Biology, Weizmann Institute of Science and a lead researcher of this work, said, "p53 is a major player in many cancers, and our new findings regarding the role of miR-34a in exerting its effects, has major therapeutic implications. One can envision a therapeutic based on mimicking mir-34a, in p53-negative cancers, thus overcoming part of the negative effects of missing this important tumor suppressor." Commenting on the European patent allowance, Kenneth A. Berlin, President and Chief Executive Officer of Rosetta Genomics, said, "We are delighted to add this European patent to our growing worldwide intellectual property portfolio. This patent is important as it protects key elements of our microRNA technology to develop treatments for a variety of cancers. These claims provide significant protection for our proprietary technology, create formidable barriers to entry for any would-be competitors and offer multiple opportunities for potential drug development partnerships." "Rosetta Genomics has pioneered the development of microRNA technology. We believe we have the earliest and broadest patents and patent applications related to composition of matter on microRNAs. This provides us with the widest access to the Sanger database, which is a key differentiating factor of our technology. This new patent is important for protecting our global leadership position in microRNA technology and resulting diagnostic and therapeutic products," added Mr. Berlin.

ABOUT MIRVIEW PRODUCTS miRview are a series of microRNA-based diagnostic products offered by Rosetta Genomics. miRview mets and miRview mets accurately identify the primary tumor type in primary and metastatic cancer including Cancer of Unknown Primary (CUP). miRview squamous accurately identifies the squamous subtype of non-small cell lung cancer, which carries an increased risk of severe or fatal internal bleeding and poor response to treatment for certain therapies. miRview meso diagnoses mesothelioma, a cancer connected to asbestos exposure. miRview lung accurately identifies the four main subtypes of lung cancer using small amounts of tumor cells.

miRview tests are designed to provide objective diagnostic data; it is the treating physician`s responsibility to diagnose and administer the appropriate treatment. In the U.S. alone, Rosetta Genomics estimates that 200,000 patients a year may benefit from the miRview mets and miRview mets test, 60,000 from miRview squamous, 60,000 from miRview meso and more than 1 million patients worldwide from miRview lung. The Company`s tests are offered directly by Rosetta Genomics in the U.S., and through distributors around the globe. For more information, please visit Parties interested in ordering the test can contact Rosetta Genomics at (215) 382-9000 ext. 309.

ABOUT MICRORNAS microRNAs (miRNAs) are recently discovered, small RNAs that act as master regulators of protein synthesis, and have been shown to be highly effective biomarkers. The unique advantage of microRNAs as biomarkers lies in their high tissue specificity, and their exceptional stability in the most routine preservation methods for biopsies, including Formalin Fixed Paraffin Embedded (FFPE) block tissue and fine needle aspirate (FNA) cell blocks. It has been suggested that their small size (19 to 21 nucleotides) enables them to remain intact in FFPE blocks, as opposed to messenger RNA (mRNA), which tends to degrade rapidly. In addition, early preclinical data has shown that by controlling the levels of specific microRNAs, cancer cell growth may be reduced.

AXIOM GOLD AND SILVER CORPORATION (OTCBB: AXIO) "Up 38.46% on Thursday" Detailed Quote: Axiom Gold and Silver Corp. engages in the discovery, exploration, and development of precious metal properties in Mexico, Chile, and Argentina.

It holds interests in the Aurora project covering approximately 570 hectares and the Gavilan project comprising approximately 724.1028 hectares located in Sonora, Mexico. The company was formerly known as TC Power Management Corp. and changed its name to Axiom Gold and Silver Corp. in January 2011. Axiom Gold and Silver Corp. was founded in 2007 and is based in Oro Valley, Arizona.

AXIO News:

No recent news for Axiom Gold and Silver Corp. (OTCBB: AXIO).

ONTECO CORPORATION (OTC: ONTC) "Up 30.00% on Thursday" Detailed Quote: Onteco Corporation was founded to develop innovative, practical and cost-effective solutions to some of the most significant environmental challenges facing us today. Additionally, these solutions must show promise of generating significant, ongoing profits for the company. The company determined that one industry that meets these criteria is the Energy Saving Lighting Industry, and as a result acquired NexPhase Lighting, Inc., in February 2011.

ONTC News:

April 19 - Onteco Corporation, ONTC, Subsidiary, NexPhase Lighting, Inc., Harvesting Over $100,000 in Con Edison Rebates for Othmer Hall Project Onteco Corporation (OTC: ONTC) (the "Company", or "Onteco") announced that its subsidiary, NexPhase Lighting, Inc. ("NexPhase"), has begun successfully harvesting rebates which will total over $100,000 for its previously announced Othmer Hall Project, for the use of NexPhase`s high efficiency, high quality, LED intelligent lighting fixtures. The rebates are from the inclusion of NexPhase`s LED products in the Con Edison Marketing Partner program.

"This is an excellent payback for our client in selecting our products, and reaffirms the value of our cutting-edge LED technology," Dror Svorai, President of the Company, stated. "We only recently joined the Con Edison Marketing Partner program in order to take advantage of its many opportunities, and are delighted to have Con Ed`s program kicking in by already issuing significant rebate checks to our first, major customer in their region." He added, "We have no doubt that being able to offer, and demonstrate the issuance of, such rebates on our excellent products will provide a strong purchase incentive to our future customers." ABOUT CONSOLIDATED EDISON, INC.

Consolidated Edison, Inc. is one of the nation`s largest investor-owned energy companies, with approximately $13 billion in annual revenues and $36 billion in assets. The company provides a wide range of energy-related products and services to its customers through the following subsidiaries:

Consolidated Edison Company of New York, Inc., a regulated utility providing electric, gas, and steam service in New York City and Westchester County, New York; Orange and Rockland Utilities, Inc., a regulated utility serving customers in a 1,350 square mile area in southeastern New York state and adjacent sections of northern New Jersey and northeastern Pennsylvania; Consolidated Edison Solutions, Inc., a retail energy supply and services company; Consolidated Edison Energy, Inc., a wholesale energy supply company; and Consolidated Edison Development, Inc., a company that participates in infrastructure projects.


NexPhase Lighting, Inc. is a designer and developer of proprietary high quality LED (light-emitting diode) lighting fixtures and control systems for commercial applications. It believes its products will be the lowest cost, highest efficacy fixtures available in the LED Lighting Industry. All NexPhase lighting products incorporate its proprietary "NexSense Technology", which provides benefits well beyond the generally acknowledged advantages of all other LED lighting fixtures. NexSense control systems use a unique, "patent pending` wireless protocol, which provides for an unsurpassed reduction in architecture and infrastructure installation cost in commercial applications, as well as significantly reduced maintenance and ongoing operation costs.

EVCARCO INCORPORATED (OTC: EVCA) "Up 100.00% on Thursday" Detailed Quote: EVCARCO, Inc. is the first automotive retail group dedicated to deploying a coast-to-coast network of environmentally friendly franchised dealerships and vehicles. EVCARCO is bringing to market the most advanced clean technologies available in plug-in electric, alternative fuel, and pre-owned hybrid vehicles from multiple manufactures. EVCARCO Future Driven EVCA News:

March 22 - EVCARCO`s Corporate Development Update Regarding Its Future Driven Brand EVCARCO Inc. (OTCBB: EVCA), a Future Driven Automotive Retail Group, announced updates to the shareholders and investment community on recent corporate developments, future plans, growth strategies, capital needs and changes to its share structure.

The Company has been working diligently to cultivate several, potentially valuable joint partnerships, identify new markets with products that provide carbon reduction technologies, sales channels, and sources of revenue.

As the Company moves forward, it continues to operate from its Micro-New Car Dealership in Ft. Worth, Texas, that has generated cumulative gross revenues of $2,208,948.00, as of the last reported period of September 30, 2011. These revenues represent sales of new electric cars, EV charging stations, and pre-owned vehicles. The Company also continues to expose and market its Master Franchise and Single Locations Franchises opportunities of the Future Driven Dealership Franchise.

On February 22, 2012, the Company announced that it signed a Memorandum of Understanding (MOU) with HFX Laboratories, Inc. regarding the market development, testing and licensing of the HFX4 Hydrogen Hybrid Combustion/Fuel Enhancement Systems. The Company is currently conducting tests of the HFX4 Hybrid System. The system produces hydrogen for use as a catalyst in the vehicle`s combustion system. The hydrogen catalyst is introduced into the vehicle`s air intake to completely utilize the fuel in the combustion process. The goal is to find in EVCA`s Due Diligence, results of 20% to 35% improvement in MPG and a reduction in emissions in the range of 60%, depending on engine efficiency.

Mack Sanders, CEO of EVCARCO, stated, "We have continued to work on expanding and growing acceptance of environmentally friendly vehicles. With recent increases in gasoline and diesel, we expect more consumers will feel the pain at the pump and embrace our products." Effective November 30, 2011, the Company amended its Articles of Incorporation to increase authorized capital. The increase was necessary in order to accommodate conversion of debt taken on over the same year. As of the date of this release, significant portion of the convertible notes payable has been paid off.

AMERICAN SIERRA GOLD CORPORATION (OTCBB: AMNP) "Up 117.39% on Thursday" Detailed Quote: American Sierra Gold Corp. is a publicly traded independent gold exploration company headquartered in Reno, Nevada. Shareholders and prospective investors are encouraged to call investor relations at 1-888-279-3921 or visit American Sierra Gold Corp`s website at

AMNP News:

No recent news for American Sierra Gold Corp. (OTCBB: AMNP). is located at 3533 Twin Lakes Drive, Prosper, TX 75078, Telephone: (972) 546-3740, Email: email address is being protected from spam bots, you need Javascript enabled to view it.

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on or one of our affiliate companies.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

Information contained in our report will contain "forward looking statements" as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward-looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company`s most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements.

We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company`s plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company`s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at and FINRA at

Disclosure: and affiliates have been not been compensated by any of the companies covered in this release.


ABOUT OTCPICKS.COM is an Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Profile Research Reports authored by our financial writers. We publish a daily Newsletter to subscribers, and we publish our Daily Market Movers Digest which is sent out on the M2 Presswire several times daily highlighting hot OTC and OTCBB stocks. To feature a company on our web site or in our daily Newsletter or Market Mover's Digest, please contact our publisher, Brian Dean at 972-546-3740, or via email at

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. This disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE: The employees are NOT Registered as an Investment Advisor in any jurisdiction whatsoever.

Release of Liability: Through use of this website viewing or using you agree to hold, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a representation by the publisher nor a solicitation of the purchase or sale of any securities. has not been compensated by any of the companies covered in this release. For a complete list of disclosures go to . The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. and its affiliates are not registered investment advisors or a broker dealers. has been advised that the investments in companies profiled are considered to be high risk and use of the information provided is at the investor's sole risk. also advises that the purchase of such high risk securities may result in the loss of some or all of the investment. Investors should not rely solely on the information presented. Rather, investors should use the information provided by the profiled companies as a starting point for doing additional independent research on the profiled companies in order to allow the investor to form his or her own opinion regarding investing in the profiled companies. Factual statements made by the profiled companies are made as of the date stated and are subject to change without notice. Investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor`s entire investment may be lost or impaired due to the speculative nature of the companies profiled. makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through owners may or may not hold positions in the companies that are profiled.

The information contained herein contains forward-looking information within the meaning of Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 including statements regarding expected continual growth of the company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect the company's actual results of operation. Factors that could cause actual results to differ include the size and growth of the market for the company's products, the company`s ability to fund its capital requirements in the near term and in the long term, pricing pressures, unforeseen and/or unexpected circumstances in happenings, pricing pressures, etc. Investing in securities is speculative and carries risk. Past performance does not guarantee future results.

Third Party Web Sites and Information: and newsletter may provide hyperlinks to third party websites or access to third party content. does not control, endorse, or guarantee content found in such sites. You agree that is not responsible for any content, associated links, resources, or services associated with a third party site. You further agree that shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only.


Disclosure Details:

CONTACT: Brian Dean, Publisher,
Tel: +1 972 546 3740
EMail :

See OTC Picks's website for full disclaimer. OTC Picks may have received compensation for stock picks.
While sales is only a facet of marketing, you must take into consideration the tremendous effect that takes place even when a sale isn't made. Burberry Outlet , The alone complete best way to accretion beef accumulation is by agency of concrete exercise. Mulberry Outlet , The dashboard helps focus on outcomes and goals that are to be achieved. ray ban , This may be a bit intimidating at first, but it is surely a pleasure to watch a dog get creative and offer behaviors. Ray Ban Espana , The design looks is identical to the NVIDIA GeForce GTX 760 reference card, so the video outputs are the same.. Cheap Ray Ban Sunglasses , And Yes you are correct God was and is All That Is. Hermes Outlet , There are a number of SEO companies spread out all over the India, but only some of them are capable to bring positive result for you. tory burch outlet, The point was that you don't want to write anything that could create an issue for you in the present or the future.. Chanel Outlet, The lure of the spice trade not only sparked the interest of merchants, but also for bandits who lived near or along the routes of the Silk Road. nike outlet, It is important to note that leishmaniasis can spread via needlesharing and contaminated injection equipment. Chanel Outlet !
Best source for Stock Picks and Penny Stock Picks
Disclaimer | Market Updates